Novo Nordisk A/S News - July 15, 2026

NOVO-B.CO July 15, 2026

Novo Nordisk Wins EU Approval for Wegovy Pill, First Oral Treatment

Novo Nordisk secured marketing authorization from the European Commission for a once-daily pill version of Wegovy. This is the first oral GLP-1 receptor...

NOVO-B.CO July 15, 2026

🟢 Novo Nordisk is trading 3.1% up today as shares rebound from a selloff over 2026 guidance

Novo Nordisk is trading 3.1% up at DKK 329.75 as shares stage a modest rebound from recent weakness tied to disappointing 2026 guidance and obesity drug...